MicroRNA Dysregulation in Liver and Pancreas of CMP-Neu5Ac Hydroxylase Null Mice Disrupts Insulin/PI3K-AKT Signaling

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kwon, Deug Nam ^a   Chang, Byung Soo ^b   Kim, Jin Hoi ^a  

^a Konkuk University   (South Korea)

^b Hanseo University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CMP N ACETYLNEURAMINIC ACID HYDROXYLASE; INSULIN; MICRORNA; MICRORNA 155 5P; MICRORNA 15A 5P; MICRORNA 16 5P; MICRORNA 29A 3P; MICRORNA 29B 3P; MICRORNA 425 5P; MICRORNA 503 5P; N ACETYLNEURAMINIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; CMPACETYLNEURAMINATE MONOOXYGENASE; MIXED FUNCTION OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; GENE EXPRESSION; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; MALE; MOLECULAR MECHANICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; COMPUTER SIMULATION; DEFICIENCY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LIVER; METABOLISM; PANCREAS; REPRODUCIBILITY;

MUS;

ANIMALS; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN; LIVER; MICE, INBRED C57BL; MICRORNAS; MIXED FUNCTION OXYGENASES; PANCREAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84935844640     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/236385     Document Type: Article

References (27)

1. H. Smit, W. Gaastra, J. P. Kamerling, J. F. Vliegenthart, and F. K. de Graaf, "Isolation and structural characterization of the equine erythrocyte receptor for enterotoxigenic Escherichia coli K99 fimbrial adhesin, " Infection and Immunity, vol. 46, no. 2, pp. 578-584, 1984.
2. R. Laufs and J. Heesemann, "Serologic diagnosis and prophylaxis of virus hepatitis, " Offentliche Gesundheitswesen, vol. 46, no. 11, pp. 578-581, 1984.
3. H.-H. Chou, H. Takematsu, S. Diaz et al., "A mutation in human CMP-sialic acid hydroxylase occurred after the Homopan divergence, " Proceedings of theNationalAcademy of Sciences of the United States of America, vol. 95, no. 20, pp. 11751-11756, 1998.
4. S. Kelm, R. Schauer, and P. R. Crocker, "The Sialoadhesins-a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily, " Glycoconjugate Journal, vol. 13, no. 6, pp. 913-926, 1996.
5. A. Irie, S. Koyamat, Y. Kozutsumi, T. Kawasaki, and A. Suzuki, "The molecular basis for the absence of N-glycolylneuraminic acid in humans, " The Journal of Biological Chemistry, vol. 273, no. 25, pp. 15866-15871, 1998.
6. T. Hayakawa, Y. Satta, P. Gagneux, A. Varki, and N. Takahata, "Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11399-11404, 2001.
7. A. Varki, "Uniquely human evolution of sialic acid genetics and biology, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 8939-8946, 2010.
8. N. M. Varki, E. Strobert, E. J. Dick Jr., K. Benirschke, and A. Varki, "Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology, " Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 365-393, 2011.
9. M. Hedlund, P. Tangvoranuntakul, H. Takematsu et al., "Nglycolylneuraminic acid deficiency in mice: implications for human biology and evolution, " Molecular and Cellular Biology, vol. 27, no. 12, pp. 4340-4346, 2007.
10. K. Chandrasekharan, J. H. Yoon, Y. Xu et al., "A human-specific deletion in mouse Cmah increases disease severity in the mdx model of duchenne muscular dystrophy, " Science Translational Medicine, vol. 2, no. 42, Article ID42ra54, 2010.
11. Y. Naito, H. Takematsu, S. Koyama et al., "Germinal center marker GL7 probes activation-dependent repression of Nglycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation, " Molecular and Cellular Biology, vol. 27, no. 8, pp. 3008-3022, 2007.
12. S. Kavaler, H. Morinaga, A. Jih et al., "Pancreatic β-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency, " The FASEB Journal, vol. 25, no. 6, pp. 1887-1893, 2011.
13. K. Chen and N. Rajewsky, "The evolution of gene regulation by transcription factors and microRNAs, " Nature Reviews Genetics, vol. 8, no. 2, pp. 93-103, 2007.
14. Y. Li and K. V. Kowdley, "MicroRNAs in common human diseases., " Genomics, proteomics & bioinformatics, vol. 10, no. 5, pp. 246-253, 2012.
15. M. N. Poy, L. Eliasson, J. Krutzfeldt et al., "A pancreatic isletspecific microRNAregulates insulin secretion, " Nature, vol. 432, no. 7014, pp. 226-230, 2004.
16. A. He, L. Zhu, N. Gupta, Y. Chang, andF. Fang, "Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes, "Molecular Endocrinology, vol. 21, no. 11, pp. 2785-2794, 2007.
17. M. Trajkovski, J. Hausser, J. Soutschek et al., "MicroRNAs 103 and 107 regulate insulin sensitivity, " Nature, vol. 474, no. 7353, pp. 649-653, 2011.
18. M. N. Poy, J. Hausser, M. Trajkovski et al., "miR-375 maintains normal pancreatic α-and β-cell mass, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5813-5818, 2009.
19. H. Y. Ling, H. S. Ou, S. D. Feng et al., "Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3t3-l1 adipocytes, " Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 9, pp. e32-e39, 2009.
20. A. Davalos, L. Goedeke, P. Smibert et al., "miR-33a/b contribute to the regulation of fatty acidmetabolism and insulin signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 22, pp. 9232-9237, 2011.
21. G. L. Papadopoulos, P. Alexiou, M. Maragkakis, M. Reczko, and A. G. Hatzigeorgiou, "DIANA-mirPath: integrating human and mouse microRNAs in pathways, " Bioinformatics, vol. 25, no. 15, pp. 1991-1993, 2009.
22. V. R. Sopasakis, P. Liu, R. Suzuki et al., "Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation, " Cell Metabolism, vol. 11, no. 3, pp. 220-230, 2010.
23. W. Langhans, "Role of the liver in the control of glucoselipid utilization and body weight, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, no. 4, pp. 449-455, 2003.
24. L. Pirola, S. Bonnafous, A. M. Johnston, C. Chaussade, F. Portis, and E. van Obberghen, "Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6muscle cells, " The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15641-15651, 2003.
25. T. Haruta, T. Uno, J. Kawahara et al., "A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1, " Molecular Endocrinology, vol. 14, no. 6, pp. 783-794, 2000.
26. T. M. Pederson, D. L. Kramer, and C. M. Rondinone, "Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation, " Diabetes, vol. 50, no. 1, pp. 24-31, 2001.
27. Y. Zick, "Insulin resistance: a phosphorylation-based uncoupling of insulin signaling, " Trends in Cell Biology, vol. 11, no. 11, pp. 437-441, 2001.